Draft guidance on management of rolling reviews for drug submissions: Performance targets and standards, cancellation
The time to complete the screening of a drug submission with a rolling review is 25 days. Once the screening acceptance letter is issued, the review 1 period would begin. The submission would immediately be placed on “rolling review” until Health Canada receives all of the missing information, as indicated in the notice.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Similar records